uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
VEGFR3 does not sustain retinal angiogenesis without VEGFR2
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Immunology, Genetics and Pathology, Vascular Biology.
Show others and affiliations
2015 (English)In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 112, no 3, 761-766 p.Article in journal (Refereed) Published
Abstract [en]

Angiogenesis, the formation of new blood vessels, is regulated by vascular endothelial growth factors (VEGFs) and their receptors (VEGFRs). VEGFR2 is abundant in the tip cells of angiogenic sprouts, where VEGF/VEGFR2 functions upstream of the delta-like ligand 4 (DLL4)/Notch signal transduction pathway. VEGFR3 is expressed in all endothelia and is indispensable for angiogenesis during early embryonic development. In adults, VEGFR3 is expressed in angiogenic blood vessels and some fenestrated endothelia. VEGFR3 is abundant in endothelial tip cells, where it activates Notch signaling, facilitating the conversion of tip cells to stalk cells during the stabilization of vascular branches. Subsequently, Notch activation suppresses VEGFR3 expression in a negative feedback loop. Here we used conditional deletions and a Notch pathway inhibitor to investigate the cross-talk between VEGFR2, VEGFR3, and Notch in vivo. We show that postnatal angiogenesis requires VEGFR2 signaling also in the absence of Notch or VEGFR3, and that even small amounts of VEGFR2 are able to sustain angiogenesis to some extent. We found that VEGFR2 is required independently of VEGFR3 for endothelial DLL4 up-regulation and angiogenic sprouting, and for VEGFR3 functions in angiogenesis. In contrast, VEGFR2 deletion had no effect, whereas VEGFR3 was essential for postnatal lymphangiogenesis, and even for lymphatic vessel maintenance in adult skin. Knowledge of these interactions and the signaling functions of VEGFRs in blood vessels and lymphatic vessels is essential for the therapeutic manipulation of the vascular system, especially when considering multitargeted antiangiogenic treatments.

Place, publisher, year, edition, pages
2015. Vol. 112, no 3, 761-766 p.
Keyword [en]
Notch, lymphangiogenesis, anti-angiogenesis, VEGFC, VEGFD
National Category
Other Medical Sciences not elsewhere specified
URN: urn:nbn:se:uu:diva-246366DOI: 10.1073/pnas.1423278112ISI: 000348040700043PubMedID: 25561555OAI: oai:DiVA.org:uu-246366DiVA: diva2:793418
Available from: 2015-03-06 Created: 2015-03-05 Last updated: 2015-03-06Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Mäkinen, Taija
By organisation
Vascular Biology
In the same journal
Proceedings of the National Academy of Sciences of the United States of America
Other Medical Sciences not elsewhere specified

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 265 hits
ReferencesLink to record
Permanent link

Direct link